Author:
Ngwu PE,Ihedoro IE,Kalu EI
Abstract
Introduction/Background: Benign Prostatic Hyperplasia (BPH) is characterized by narrowing of the prostatic urethra with resultant difficulty in passing urine, stasis, and a predisposition to urinary tract infection. The objective of this study is to identify the prevalence of urinary tract infections, common organisms isolated, their antimicrobial sensitivity pattern, and the relationship of co-morbidities with urinary tract infection in this population. Materials and methods: All patients who presented to our urology team with bladder outlet obstruction secondary to benign prostatic hyperplasia between January 2020 and January 2021 were included. Information on age, occupation, co-morbid conditions, urine microscopy, culture, and sensitivity patterns were obtained and analyzed using SPSS version 25. Midstream urine samples were collected from 172 BPH patients. Microscopy, culture, and antibiotic susceptibility tests were carried out. Results: From our study, the prevalence of bacteriuria was 67.9% with the 65-74 and 45-54 age groups having the highest and the least prevalence of bacteriuria (88.9% and 33.3% respectively). The most common organisms cultured from their urine were Pseudomonas (17.9%), E. coli (14.3%), Coliforms (10.7%), and Klebsiella (10.7%). Sensitivity patterns of these microorganisms revealed the highest sensitivity to the fluoroquinolones (25.9%) followed by Nitrofurantoin (14.8%) and Ceftriaxone and Cefoxitin (7.4%). The least sensitivity was to Augmentin and Gentamycin. Conclusion: Bacteriuria is common in patients with BPH. Pseudomonas spp was the commonest isolated organism in our study and most isolated organisms were susceptible to the fluoroquinolones.
Publisher
Peertechz Publications Private Limited
Subject
Industrial and Manufacturing Engineering,General Business, Management and Accounting,Materials Science (miscellaneous),Business and International Management
Reference19 articles.
1. 1. Chan SW. Pathology and Medical Therapy of Benign Prostatic Hyperplasia. The Hong Kong Medical Diary, 16, 4-7. - References - Scientific Research Publishing [cited 2021 Sep 24]. Available from: 2011; https://scirp.org/reference/ReferencesPapers.aspx?ReferenceID=1418905
2. 2. (PDF) Benign prostatic hyperplasia and lower urinary tract symptoms: evidence and approaches for best case management . [cited 2021 Sep 24]. Available from: https://www.researchgate.net/publication/51059325_Benign_prostatic_hyperplasia_and_lower_urinary_tract_symptoms_evidence_and_approaches_for_best_case_management
3. 3. Edlin RS, Heyns CF, Van Vuuren SP, Zarrabi AD. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention. S Afr J Surg. 2012 Nov 12;50(4):127-30. doi: 10.7196/sajs.1095. PMID: 23217554.
4. 4. Oshodi AJ, Nwabuisi C, Popoola AA, Edungbola LD, Agbede OO, Ii AAA, et al. Bacterial Uropathogen among Benign Prostatic Hyperplasia Patients at a Tertiary Hospital in Nigeria. 2015;(March):22-7.
5. 5. Chedi B, Wannang N, Halliru M, Bichi L. Seven months retrospective study on Urinary Tract Infection among patients at Aminu Kano Teaching Hospital, Kano - Nigeria. Bayero J Pure Appl Sci . 2011 Feb 23 ,2021 ;Sep 24,2(2):95-8. Available from: https://www.ajol.info/index.php/bajopas/article/view/63791